n(g),n(g')-dimethyl-l-arginine has been researched along with Blood Poisoning in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-arginine and ADMA levels were higher in neonates with sepsis compared to controls (p = 0." | 9.20 | Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock. ( Aydemir, O; Bas, AY; Demirel, N; Ozcan, B; Yucel, H, 2015) |
| "As modulators of nitric oxide generation, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) may play important roles in sepsis." | 8.02 | Evaluation of Biomarkers in Sepsis: High Dimethylarginine (ADMA and SDMA) Concentrations Are Associated with Mortality. ( Lynch, KL; van Wijk, XMR; Yun, C, 2021) |
| "Increased plasma concentrations of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, decreased arginine bioavailability, and mitochondrial dysfunction have been reported in adult sepsis." | 7.78 | Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis. ( Chace, DH; De Jesus, VR; Haymond, S; Ralay Ranaivo, H; Wainwright, MS; Wang, D; Weiss, SL, 2012) |
| "Impaired endothelial and microvascular function due to decreased endothelial NO bioavailability is a potential mechanism linking increased plasma ADMA with organ failure and death in sepsis." | 5.37 | Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. ( Anstey, NM; Celermajer, DS; Darcy, CJ; Davis, JS; Jones, C; McNeil, YR; Stephens, DP; Yeo, TW, 2011) |
| " In recent years, the emerging new understanding of the NO pathway has shown that an endogenously produced inhibitor of NOS, asymmetric dimethylarginine (ADMA), a host response to infection, may play an important role in the pathophysiology of sepsis as well as organ damage during ischemia-reperfusion." | 5.22 | A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach. ( Kellum, JA; Lee, Y; Singh, J, 2022) |
| "L-arginine and ADMA levels were higher in neonates with sepsis compared to controls (p = 0." | 5.20 | Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock. ( Aydemir, O; Bas, AY; Demirel, N; Ozcan, B; Yucel, H, 2015) |
| "As modulators of nitric oxide generation, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) may play important roles in sepsis." | 4.02 | Evaluation of Biomarkers in Sepsis: High Dimethylarginine (ADMA and SDMA) Concentrations Are Associated with Mortality. ( Lynch, KL; van Wijk, XMR; Yun, C, 2021) |
| "Serum concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, may contribute to endothelial dysfunction and organ failure in sepsis." | 3.79 | Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients. ( Bruensing, J; Buendgens, L; Dückers, H; Koch, A; Kunze, J; Luedde, T; Matthes, M; Tacke, F; Trautwein, C; Weiskirchen, R, 2013) |
| "Increased plasma concentrations of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, decreased arginine bioavailability, and mitochondrial dysfunction have been reported in adult sepsis." | 3.78 | Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis. ( Chace, DH; De Jesus, VR; Haymond, S; Ralay Ranaivo, H; Wainwright, MS; Wang, D; Weiss, SL, 2012) |
| "Dysfunctions of the L-arginine (L-arg)/nitric-oxide (NO) pathway are suspected to be important for the pathogenesis of multiple organ dysfunction syndrome (MODS) in septic shock." | 3.78 | L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure. ( Bierhaus, A; Brenner, T; Bruckner, T; Fleming, TH; Hofer, S; Krauser, U; Martin, E; Mieth, M; Nawroth, PP; Rosenhagen, C; Weigand, MA, 2012) |
| "Impaired endothelial and microvascular function due to decreased endothelial NO bioavailability is a potential mechanism linking increased plasma ADMA with organ failure and death in sepsis." | 1.37 | Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. ( Anstey, NM; Celermajer, DS; Darcy, CJ; Davis, JS; Jones, C; McNeil, YR; Stephens, DP; Yeo, TW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, J | 1 |
| Lee, Y | 1 |
| Kellum, JA | 1 |
| van Wijk, XMR | 1 |
| Yun, C | 1 |
| Lynch, KL | 1 |
| Koch, A | 1 |
| Weiskirchen, R | 1 |
| Kunze, J | 1 |
| Dückers, H | 1 |
| Bruensing, J | 1 |
| Buendgens, L | 1 |
| Matthes, M | 1 |
| Luedde, T | 1 |
| Trautwein, C | 1 |
| Tacke, F | 1 |
| Aydemir, O | 1 |
| Ozcan, B | 1 |
| Yucel, H | 1 |
| Bas, AY | 1 |
| Demirel, N | 1 |
| Dounousi, E | 1 |
| Torino, C | 1 |
| Pizzini, P | 1 |
| Cutrupi, S | 1 |
| Panuccio, V | 1 |
| D'Arrigo, G | 1 |
| Abd ElHafeez, S | 1 |
| Tripepi, G | 1 |
| Mallamaci, F | 1 |
| Zoccali, C | 1 |
| Mortensen, KM | 1 |
| Itenov, TS | 1 |
| Haase, N | 1 |
| Müller, RB | 1 |
| Ostrowski, SR | 1 |
| Johansson, PI | 1 |
| Olsen, NV | 1 |
| Perner, A | 1 |
| Søe-Jensen, P | 1 |
| Bestle, MH | 1 |
| Davis, JS | 1 |
| Darcy, CJ | 1 |
| Yeo, TW | 1 |
| Jones, C | 1 |
| McNeil, YR | 1 |
| Stephens, DP | 1 |
| Celermajer, DS | 1 |
| Anstey, NM | 1 |
| Weiss, SL | 1 |
| Haymond, S | 1 |
| Ralay Ranaivo, H | 1 |
| Wang, D | 1 |
| De Jesus, VR | 1 |
| Chace, DH | 1 |
| Wainwright, MS | 1 |
| Brenner, T | 1 |
| Fleming, TH | 1 |
| Rosenhagen, C | 1 |
| Krauser, U | 1 |
| Mieth, M | 1 |
| Bruckner, T | 1 |
| Martin, E | 1 |
| Nawroth, PP | 1 |
| Weigand, MA | 1 |
| Bierhaus, A | 1 |
| Hofer, S | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Blood Poisoning
| Article | Year |
|---|---|
A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach.
Topics: Animals; Arginine; Humans; Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Sepsis | 2022 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Blood Poisoning
| Article | Year |
|---|---|
Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Humans; Infant, Newborn; Male; Multiple Organ Fa | 2015 |
7 other studies available for n(g),n(g')-dimethyl-l-arginine and Blood Poisoning
| Article | Year |
|---|---|
Evaluation of Biomarkers in Sepsis: High Dimethylarginine (ADMA and SDMA) Concentrations Are Associated with Mortality.
Topics: Arginine; Biomarkers; Humans; Sepsis | 2021 |
Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Critical Ill | 2013 |
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth F | 2016 |
High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
Topics: Aged; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide; Proportional Hazards Models; Sepsis | 2016 |
Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.
Topics: Adult; Aged; Arginine; Biological Availability; Case-Control Studies; Endothelium, Vascular; Female; | 2011 |
Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis.
Topics: Adolescent; Arginine; Carnitine; Case-Control Studies; Child; Child, Preschool; Enzyme-Linked Immuno | 2012 |
L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure.
Topics: Aged; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Failure, Acute; Male; Middl | 2012 |